Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Large Cap

Large Cap

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • General
  • Health Care
  • Large Cap
  • News
  • Trading Ideas
  • Upgrades

Sleep Device Player ResMed’s Potential Obstacles: Analyst Weighs Obesity Drugs & Philips’ Re-Entry

By Vandana Singh
September 6, 2:39 PM
Needham upgraded ResMed Inc (NYSE: RMD) from a Hold to Buy rating with a price target of $180

PHG

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Equities
  • Initiation
  • Large Cap
  • Markets
  • News
  • Price Target
  • Trading Ideas

Fair Isaac Fairly Capable To See Further Upside Thanks To Competitive FICO Score Business: Analyst

By Lekha Gupta
September 6, 2:26 PM
Raymond James analyst Patrick O'Shaughnessy initiated coverage on Fair Isaac Corp (NYSE: FICO) with an Outperform rating 

FICO

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Johnson & Johnson Cancer Drug Rybrevant Shows Improvement In Broader Lung Cancer Population

By Vandana Singh
September 6, 2:11 PM
Janssen, a unit of Johnson & Johnson (NYSE: JNJ), 

AZN

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Equities
  • Large Cap
  • Markets
  • News
  • Price Target
  • Trading Ideas
  • Upgrades

Celanese Poised For Growth In Global Manufacturing Recovery And Organic Opportunities: Analyst

By Lekha Gupta
September 6, 12:43 PM
KeyBanc Capital Markets analyst Aleksey Yefremov upgraded Celanese Corp (NYSE: CE) to Overweight from Sector Weight 

CE

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Equities
  • Initiation
  • Large Cap
  • Markets
  • Trading Ideas

Trade Desk’s Technological Innovation Drives Dominance: Analyst Foresees Revenue Surge In Coming Years

By Lekha Gupta
September 6, 12:40 PM
William Blair analyst Ralph Schackart initiated coverage on The Trade Desk Inc (NASDAQ: TTD) 

TTD

Read More
2 minute read
  • Financing
  • General
  • Large Cap
  • Markets
  • News
  • Startups
  • Tech
  • Topics

Microsoft-Backed Startup D-Matrix To Compete With Nvidia In Bid For AI Dominance

By AJ Fabino
September 6, 12:29 PM
The chips are down in the artificial intelligence (AI) market, and Nvidia Corporation’s (NASDAQ: NVDA) stronghold appears unshakeable.

MSFT

Read More
2 minute read
  • Entertainment
  • General
  • Large Cap
  • Media
  • Mid Cap
  • News
  • Topics
  • Travel

Delta, Air Canada Passengers Face Hard Decisions When Confronted With Bodily Fluids

By AJ Fabino
September 6, 11:55 AM
Passengers aboard flights on two leading airlines, Delta Air Lines, Inc. (NYSE: DAL) and Air Canada (OTCMKTS: ACDVF), were recently confronted with situations involving bodily fluids, leading to some real discomfort and tough ch

ACDVF

Read More
1 minute read
  • Biotech
  • Contracts
  • General
  • Health Care
  • Large Cap
  • Movers
  • News
  • Penny Stocks

Why Is Infectious Diseases Focused Cidara Therapeutics Stock Trading Higher Today?

By Vandana Singh
September 6, 11:26 AM
Cidara Therapeutics Inc (NASDAQ: CDTX) shares are trading higher after the company announced that Janssen Pharmaceuticals Inc, a unit of Johnson & Johnson (NYSE: JNJ), decided to pr

CDTX

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Is Moderna’s New Vaccine the Answer to the Highly Mutated BA.2.86 COVID-19 Variant?

By Vandana Singh
September 6, 9:11 AM
Moderna Inc's (NASDAQ: MRNA) clinical trial data from its research assay confirm that its updated COVID-19 vaccine generates an 8.7-fold increase in neutralizing antibodies in humans against BA.2.86 (Pirola), 

MRNA

Read More
1 minute read
  • Equities
  • Large Cap
  • Markets
  • Media
  • News

C&S, SoftBank Near Deal To Purchase Stores From Kroger, Albertsons: Report

By Lekha Gupta
September 6, 8:55 AM
C&S Wholesale Grocers, backed by SoftBank Corp (OTCPK: SFBQF), is reportedly approaching a deal to buy stores from The Kroger Company (NYSE: KR) and Albertsons Companies, Inc. (NYSE:

ACI

Posts pagination

Previous 1 … 219 220 221 … 437 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service